Immunological aspects of radiotherapy

Radiation Oncology

Volumn 9, Issue 1, 2014, Pages 1-4

  Scheithauer, Heike ^a   Belka, Claus ^a   Lauber, Kirsten ^a   Gaipl, Udo S ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CONTROL; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; EDITORIAL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; RADIOIMMUNOTHERAPY; ANIMAL; IMMUNOLOGY; IMMUNOTHERAPY; NEOPLASMS; ONCOLOGY; PROCEDURES; TRENDS;

ANIMALS; HUMANS; IMMUNOTHERAPY; NEOPLASMS; RADIATION ONCOLOGY; RADIOTHERAPY;

EID: 84906839605     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-9-185     Document Type: Editorial

References (19)

1. Orth M, Lauber K, Niyazi M, Friedl AA, Li M, Maihofer C, Schuttrumpf L, Ernst A, Niemoller OM, Belka C. Current concepts in clinical radiation oncology. Radiat Environ Biophys 2014, 53:1-29. 10.1007/s00411-013-0497-2, 3935099, 24141602.
2. Hennel R, Brix N, Seidl K, Ernst A, Scheithauer H, Belka C, Lauber K. Release of monocyte migration signals by breast cancer cell lines after ablative and fractionated gamma-irradiation. Radiat Oncol 2014, 9:85. 10.1186/1748-717X-9-85, 3994291, 24666643.
3. Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annu Rev Immunol 2013, 31:51-72. 10.1146/annurev-immunol-032712-100008, 23157435.
4. Lauber K, Ernst A, Orth M, Herrmann M, Belka C. Dying cell clearance and its impact on the outcome of tumor radiotherapy. Front Oncol 2012, 2:116. 3438527, 22973558.
5. Rubner Y, Muth C, Strnad A, Derer A, Sieber R, Buslei R, Frey B, Fietkau R, Gaipl US. Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines. Radiat Oncol 2014, 9:89. 10.1186/1748-717X-9-89, 3994240, 24678590.
6. Tabatabai G, Stupp R, van den Bent MJ, Hegi ME, Tonn JC, Wick W, Weller M. Molecular diagnostics of gliomas: the clinical perspective. Acta Neuropathol 2010, 120:585-592. 10.1007/s00401-010-0750-6, 20862485.
7. Hegde M, Bielamowicz KJ, Ahmed N. Novel approaches and mechanisms of immunotherapy for glioblastoma. Discovery Med 2014, 17:145-154.
8. Murphy ME. The HSP70 family and cancer. Carcinogenesis 2013, 34:1181-1188. 10.1093/carcin/bgt111, 3670260, 23563090.
9. Gehrmann M, Specht HM, Bayer C, Brandstetter M, Chizzali B, Duma M, Breuninger S, Hube K, Lehnerer S, van Phi V, Sage E, Schmid TE, Sedelmayr M, Schilling D, Sievert W, Stangl S, Multhoff G. Hsp70-a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck. Radiat Oncol 2014, 9:131. 10.1186/1748-717X-9-131, 4075935, 24912482.
10. Langer CJ. Exploring biomarkers in head and neck cancer. Cancer 2012, 118:3882-3892. 10.1002/cncr.26718, 22281752.
11. Hoglund P. DNA damage and tumor surveillance: one trigger for two pathways. Sci STKE 2006, (317):2. doi:10.1126/stke.3172006pe2.
12. Rosental B, Appel MY, Yossef R, Hadad U, Brusilovsky M, Porgador A. The effect of chemotherapy/radiotherapy on cancerous pattern recognition by NK cells. Curr Med Chem 2012, 19:1780-1791. 10.2174/092986712800099730, 22414084.
13. Fotin-Mleczek M, Zanzinger K, Heidenreich R, Lorenz C, Kowalczyk A, Kallen K-J, Huber SM. mRNA-based vaccines synergize with radiation therapy to eradicate established tumors. Radiat Oncol 2014, 9:180. 10.1186/1748-717X-9-180, 25127546.
14. Aldrich JF, Lowe DB, Shearer MH, Winn RE, Jumper CA, Kennedy RC. Vaccines and immunotherapeutics for the treatment of malignant disease. Clinical Dev Immunol 2010, 2010:697158.
15. Gulley JL, Madan RA, Tsang KY, Jochems C, Marte JL, Farsaci B, Tucker JA, Hodge JW, Liewehr DJ, Steinberg SM, Heery CR, Schlom J. Immune impact induced by PROSTVAC (PSA-TRICOM), a therapeutic vaccine for prostate cancer. Cancer Immunol Res 2014, 2:133-141. 10.1158/2326-6066.CIR-13-0108, 24778277.
16. Ding J, Wu Z, Crider BP, Ma Y, Li X, Slaughter C, Gong L, Xie XS. Identification and functional expression of four isoforms of ATPase II, the putative aminophospholipid translocase. Effect of isoform variation on the ATPase activity and phospholipid specificity. J Biol Chem 2000, 275:23378-23386. 10.1074/jbc.M910319199, 10801890.
17. Wirsdorfer F, Cappuccini F, Niazman M, de Leve S, Westendorf AM, Ludemann L, Stuschke M, Jendrossek V. Thorax irradiation triggers a local and systemic accumulation of immunosuppressive CD4+ FoxP3+ regulatory T cells. Radiat Oncol 2014, 9:98. 10.1186/1748-717X-9-98, 4011772, 24766907.
18. Rodel F, Frey B, Gaipl U, Keilholz L, Fournier C, Manda K, Schollnberger H, Hildebrandt G, Rodel C. Modulation of inflammatory immune reactions by low-dose ionizing radiation: molecular mechanisms and clinical application. Curr Med Chem 2012, 19:1741-1750. 10.2174/092986712800099866, 22414082.
19. Large M, Reichert S, Hehlgans S, Fournier C, Rodel C, Rodel F. A non-linear detection of phospho-histone H2AX in EA.hy926 endothelial cells following low-dose X-irradiation is modulated by reactive oxygen species. Radiat Oncol 2014, 9:80. 10.1186/1748-717X-9-80, 3997971, 24655916.